Close Menu

NEW YORK – CareDx and Stanford University on Wednesday filed a patent infringement lawsuit against TAI Diagnostics in the United States District Court for the District of Delaware, alleging that TAI's heart transplant rejection test MyTAIHeart infringes on a patent owned by Stanford and exclusively licensed to CareDx covering a method for the non-invasive diagnosis of transplant rejection.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.